|

Clinical Study of Breast Conserving Surgery Combined With Intraoperative Radiotherapy for Early Breast Cancer

RECRUITINGSponsored by Hebei Medical University Fourth Hospital
Actively Recruiting
SponsorHebei Medical University Fourth Hospital
Started2020-11-19
Est. completion2026-11-19
Eligibility
Age55 Years+
SexFEMALE
Healthy vol.Accepted

Summary

A Single-center, open, prospective study,for analyzing the local recurrence rate, the incidence of incision complications and the aesthetic effect of intraoperative radiotherapy in early breast cancer patients after breast-conserving surgery.

Eligibility

Age: 55 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

1. Age ≥55 years old;
2. Cytology or histology confirmed invasive breast cancer or intraductal carcinoma in situ (DCIS) with a clinical stage of Tis-1N0M0;
3. Patients who are willing to preserve milk and intend to undergo breast-conserving surgery;
4. If invasive breast cancer is confirmed, the surgical margin negative ≥2mm should be met. If DCIS is confirmed, the surgical margin should be negative ≥3mm;
5. ER≥ 30% and PR≥ 1%, HER2 negative;
6. Voluntary participation in this study, signed informed consent, good compliance, cooperate with follow-up.

Exclusion Criteria:

1. Simultaneous diagnosis of bilateral or multifocal breast cancer;
2. Previous ipsilateral breast cancer and/or prior chest wall radiation therapy;
3. There are active connective tissue diseases such as scleroderma and systemic lupus erythematosus in the chest;
4. The investigators did not consider the patient suitable for participation in any other conditions of the study.

Conditions3

Breast CancerCancerHER2-negative Breast Cancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.